Allogeneic stem cell transplantation compared with chemotherapy for poor-risk Hodgkin lymphoma.

Early discharge after high-dose melphalan and peripheral blood stem cell reinfusion in patients with hematological and non-hematological disease.

Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with essential thrombocythemia.